The role of vitamin D in the carcinogenesis of breast and ovarian cancer;Rola witaminy D w karcynogenezie raka piersi i raka jajnika

Ginekologia Polska

Volumn 84, Issue 4, 2013, Pages 305-308

  Walentowicz Sadłecka, Małgorzata ^a   Sadłecki, Paweł ^a   Walentowicz, Paweł ^a   Grabiec, Marek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Breast cancer; Ovarian cancer; Vitamin D

Indexed keywords

EID: 84879194797     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Apperly F. The relation of solar radiation to cancer mortality in North America. Cancer Res. 1941, 1, 191-195.
2. Garland C, Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer?. Int J Epidemiol. 1980, 9, 227-231.
3. Grant B. Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res. 2012, 32, 223-236.
4. Holick F, Binkley C, Bischoff-Ferrari A, [et al.]. Weaver CM Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012, 97, 1153-1158.
5. Holick F. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008, 3, 1548-1554.
6. Aloia J, Patel M, Dimaano R, [et al.]. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008, 87, 1952-1958.
7. Lorenc R, Karczmarewicz E, Kryśkiewicz E, [i wsp.]. Zasady suplementacji i standardy oceny zaopatrzenia organizmu w witamine{ogonek} D w świetle jej dzialania plejotropowego. Standardy medyczne, pediatria. 2012, 9, 595-604.
8. Sutton A, MacDonald P. Vitamin D: more than a "bone-a-fide" hormone. Mol Endocrinol. 2003, 17, 777-791.
9. Souberbielle J, Body J, Lappe J, [et al.]. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010, 9, 709-715.
10. Moreno J, Krishnan A, Feldman D. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer. J Steroid Biochem Mol Biol. 2005, 97, 31-36.
11. Mocellin S. Vitamin D and cancer: Deciphering the truth. Biochim Biophys Acta. 2011, 1816, 172-178.
12. Lefkowitz E, Garland C. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994, 23, 1133-1136.
13. Grant W. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol. 2011, 3, 199-204.
14. Robsahm T, Tretli S, Dahlback A, [et al.]. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004, 15, 149-158.
15. Freedman D, Looker A, Chang S, [et al.]. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007, 99, 1594-1602.
16. Ng K, Meyerhardt JA, Wu K, [et al.]. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008, 26(18), 2984-91.
17. Mezawa H, Sugiura T, Watanabe M, [et al.]. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer. 2010, 10, 347.
18. Goodwin P, Ennis M, Pritchard K, [et al.]. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol. 2009, 27, 3757-3763.
19. Fang F, Kasperzyk J, Shui I, [et al.]. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011, 6, e18625.
20. Drake M, Maurer M, Link B, [et al.]. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol. 2010, 28,, 4191-4198.
21. Shanafelt T, Drake M, Maurer M, [et al.]. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood. 2011, 117, 1492-1498.
22. Walentowicz-Sadlecka M, Grabiec M, Sadlecki P, [et al.]. 25(OH)D3 in patients with ovarian cancer and its correlation with survival. Clin Biochem. 2012, 45, 1568-1572.
23. Tretli S, Schwartz G, Torjesen P, [et al.]. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012, 23, 363-370.
24. Palmieri C, MacGregor T, Girgis S, [et al.]. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol. 2006, 59, 1334-1336.
25. Pieta B, Grodecka-Gazdecka S, Chmaj-Wierzchowska K, [et al.]. Analysis of the odds ratio for developing breast cancer in women. Ginekol Pol. 2011, 82, 755-760.
26. Mohr S, Gorham E, Alcaraz J, [et al.]. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res. 2011, 31, 2939-2948.
27. Hill A. The envinronment and disease: association or causation?. Proc R Soc Med. 1965, 58, 295-300.
28. Lappe J, Cullen D, Haynatzki G, [et al.]. Thompson K Calcium and vitamin d supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res. 2008, 23, 741-749.
29. Bolland M, Grey A, Gamble G, [et al.]. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr. 2011, 94, 1144-1149.
30. Bolland M, Grey A, Avenell A, [et al.]. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011, 342, d2040. doi: 10.1136/bmj.d2040.
31. Krishnan A, Feldman D. Review Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011, 51, 311-336.
32. Mantell D, Owens P, Bundred N, [et al.]. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res. 2000, 87, 214-220.
33. Pearson G, Hunter T. Real-time imaging reveals that noninvasive mammary epithelial acini can contain motile cells. J Cell Biol. 2007, 179, 1555-1567.
34. Berx G, Van Roy F. Review The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 2001, 3, 289-293.
35. Pálmer H, González-Sancho J, Espada J, [et al.]. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001, 154, 369-387.
36. Lopes N, Carvalho J, Durães C, [et al.]. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer Res. 2012, 32, 249-257.
37. Grant W. Role of solar UVB irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries. Dermatoendocrinol. 2012, 4, 203-211.
38. Lefkowitz E, Garland C. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994, 23, 1133-1136.
39. Freedman D, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certi?cate based case-control study. Occup Environ Med. 2002, 59, 257-262.
40. Garland C, Mohr S, Gorham E, [et al.]. Role of ultravolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med. 2006, 31, 512-514.
41. Cook L, Neilson H, Lorenzetti D, [et al.]. A systematic literature review of vitamin D and ovarian cancer. Am J Obstet Gynecol. 2010, 203, 70.e1-70.e8.
42. Yin L, Grandi N, Raum E, [et al.]. Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecol Oncol. 2011, 121, 369-375.
43. Toriola A, Surcel H, Agborsangaya C, [et al.]. Serum 25-hydroxyvitamin D and the risk of ovarian cancer. Eur J Cancer. 2010, 46, 364-369.
44. Tworoger S, Lee I, Buring J, [et al.]. Plasma 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D and the risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007, 16, 783-788.
45. Zheng W, Danforth K, Tworoger S, [et al.]. Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer. Am J Epidemiol. 2010, 72, 70-80.
46. Arslan A, Clendenen T, Koenig K, [et al.]. Circulating vitamin D and the risk of epithelial ovarian cancer. J Oncol. 2009, 672492. doi: 10.1155/2009/672492.
47. Bakhru A Mallinger J, Buckanovich R, [et al]. Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: a study from the NHANES. Gynecol Oncol. 2010, 119, 314-318.
48. Charzewska J, Chlebna-Sokól D, Chybicka A,[ i wsp.]. Prophylaxis of vitamin D deficiency - Polish recommendation 2009. Ginekol Pol. 2010, 81, 149-153.
49. Grant W, Juzeniene A, Moan J. Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries. Scand J Public Health. 2011, 39, 70-78.